← FDA Drug Approvals (Drugs@FDA)

RIVASTIGMINE TARTRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CADILA PHARMS LTD · Approved 2017-02-13

Drug application

FDA Application #

ANDA203844

Application type

Abbreviated New Drug Application (Generic)

Brand name

RIVASTIGMINE TARTRATE

Generic name

RIVASTIGMINE TARTRATE

Active ingredients

RIVASTIGMINE TARTRATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

CADILA PHARMS LTD

Manufacturer

Nivagen Pharmaceuticals, Inc.

First approval

2017-02-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown